SecSonar.com

Intelligent Bio Solutions Inc. (INBS)

Intelligent Bio Solutions Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Intelligent Bio Solutions Inc. (INBS) is a Medical - Diagnostics & Research company based in US with a market capitalization of $1.6M. Revenue declined 1.9% year-over-year and free cash flow was negative at -$9.9M. This page tracks INBS's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 50 employees · IPO Dec 23, 2020

Valuation

Valuation & price

$4.01 · as of May 17, 2026 · -82.2% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.55

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$21.40$11.80$2.20Jul 25Dec 25Jul 26Jul 7, 25$17.00Jul 9, 25$18.20Jul 11, 25$17.70Jul 15, 25$19.00Jul 17, 25$21.40Jul 21, 25$20.30Jul 23, 25$21.20Jul 25, 25$16.10Jul 29, 25$15.90Jul 31, 25$15.80Aug 4, 25$15.20Aug 6, 25$15.60Aug 11, 25$14.40Aug 13, 25$15.10Aug 15, 25$14.70Aug 19, 25$14.60Aug 21, 25$14.70Aug 25, 25$14.70Aug 27, 25$15.90Aug 29, 25$16.20Sep 3, 25$15.80Sep 5, 25$15.50Sep 9, 25$17.60Sep 11, 25$17.30Sep 16, 25$18.80Sep 18, 25$14.20Sep 22, 25$13.45Sep 24, 25$13.60Sep 26, 25$11.20Sep 30, 25$10.20Oct 2, 25$10.80Oct 6, 25$11.40Oct 8, 25$11.45Oct 10, 25$10.70Oct 14, 25$10.80Oct 16, 25$10.30Oct 21, 25$10.60Oct 23, 25$10.20Oct 27, 25$10.00Oct 29, 25$9.51Oct 31, 25$9.77Nov 4, 25$8.43Nov 6, 25$7.81Nov 10, 25$7.85Nov 12, 25$7.93Nov 14, 25$7.20Nov 18, 25$6.90Nov 20, 25$6.42Nov 25, 25$6.61Nov 28, 25$6.60Dec 2, 25$6.61Dec 4, 25$7.47Dec 8, 25$7.10Dec 10, 25$7.24Dec 12, 25$5.60Dec 16, 25$5.50Dec 18, 25$6.99Dec 22, 25$5.75Dec 24, 25$4.98Dec 29, 25$4.30Jan 2, 26$7.89Jan 6, 26$10.70Jan 8, 26$14.31Jan 12, 26$15.26Jan 14, 26$15.60Jan 16, 26$14.60Jan 21, 26$9.87Jan 23, 26$9.51Jan 27, 26$8.86Jan 29, 26$9.00Feb 2, 26$7.86Feb 4, 26$6.96Feb 9, 26$5.71Feb 11, 26$5.25Feb 13, 26$5.02Feb 18, 26$4.83Feb 20, 26$4.56Feb 24, 26$4.14Feb 26, 26$3.91Mar 2, 26$4.46Mar 4, 26$4.39Mar 6, 26$4.06Mar 10, 26$4.10Mar 12, 26$4.02Mar 17, 26$3.71Mar 19, 26$3.44Mar 23, 26$3.44Mar 25, 26$3.35Mar 27, 26$3.22Mar 31, 26$3.35Apr 2, 26$2.75Apr 7, 26$2.68Apr 9, 26$2.55Apr 13, 26$2.46Apr 15, 26$2.78Apr 17, 26$2.66Apr 22, 26$2.76Apr 24, 26$2.55Apr 28, 26$2.42Apr 30, 26$2.45May 4, 26$2.50May 6, 26$2.41May 8, 26$2.36May 12, 26$3.18May 14, 26$4.11May 18, 26$3.65May 20, 26$2.83May 22, 26$2.57May 28, 26$2.52Jun 1, 26$2.48Jun 3, 26$2.44Jun 5, 26$2.45Jun 9, 26$2.42Jun 11, 26$2.40Jun 15, 26$2.33Jun 17, 26$2.25Jun 22, 26$2.38Jun 24, 26$2.20Jun 26, 26$2.25Jul 2, 26$2.24
$2.1552-week range$22.50
Loading valuation history…

Fundamentals

Key fundamentals

$1.6M

Market cap

-1.9%

Revenue growth (YoY)

40.9%

Gross margin

-$9.9M

Free cash flow (USD)

-$738.1K

Net debt

Net cash position

65.6%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2017 → 2025

FY 2017$0.00FY 2018$0.00FY 2019$0.00FY 2020$188.7KFY 2021$2.0MFY 2022$0.00FY 2023$1.3MFY 2024$3.1MFY 2025$3.1M
$0$3.1M

Free cash flow by year

2017 → 2025

FY 2017$-243.9KFY 2018$-5.4MFY 2019$-5.6MFY 2020$-498.6KFY 2021$-11.3MFY 2022$-3.7MFY 2023$-7.9MFY 2024$-9.8MFY 2025$-9.9M
-$243.9K-$9.9M

Gross margin by year

2021 → 2025

FY 2021100.0%FY 202326.0%FY 202445.8%FY 202540.9%
100.0%40.9%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 13, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventInterference Study InitiatedJun 16, 2026Filing
  • 8-K eventFDA Submission Study InitiatedJun 2, 2026Filing
  • 8-K eventEarnings ReleaseMay 14, 2026Filing
  • Quarterly report10-Q FiledMay 13, 2026Filing
  • 8-K eventInvestor PresentationApr 20, 2026Filing

Questions

Frequently asked questions

What is Intelligent Bio Solutions Inc.'s market cap?

Intelligent Bio Solutions Inc. (INBS) has a market capitalization of $1.6M.

What is INBS's P/E ratio?

A meaningful P/E ratio is not available for INBS — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is INBS's price-to-book (P/B) ratio?

INBS trades at 0.55 times book value per share.

Are insiders buying INBS stock?

SEC Form 4 filings show no open-market insider buys at Intelligent Bio Solutions Inc. in the last 90 days (0 sells).

Same arena

Related companies in Medical - Diagnostics & Research

ISPC

iSpecimen Inc.

$437K

BGLC

BioNexus Gene Lab Corp.

$4.4M

TRIB

Trinity Biotech plc

$7.4M

BIAF

bioAffinity Technologies, Inc.

$7.7M

NOTV

Inotiv, Inc.

$9.8M

VNRX

VolitionRx Limited

$15.6M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.